An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma

Prognostic value of microRNA expression in operable non-small cell lung cancer patients

(2014) M Skrzypski et al.   BRITISH JOURNAL OF CANCER

Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?

(2014) Frank Berger et al.   Theranostics

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers

(2014) Jin Ahn et al.   Genome Medicine

The Impact of Genomic Changes on Treatment of Lung Cancer

(2013) Stephanie Cardarella et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3

(2013) Jun Zhao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNAs Contribute to Promyelocyte Apoptosis in As2O3-Treated APL Cells

(2013) Haihai Liang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma

(2013) W. Meng et al.   CLINICAL CANCER RESEARCH

Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer

(2013) Hong Yu et al.   GENE

Smoking and microRNA dysregulation: a cancerous combination

(2013) Navneet Momi et al.   TRENDS IN MOLECULAR MEDICINE

Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype

(2013) Jae Yun Lim   WORLD JOURNAL OF GASTROENTEROLOGY

Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort

(2012) Amy K. Ferketich et al.   CANCER

MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer

(2012) Yan Lu et al.   CARCINOGENESIS

miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive Potential In Vitro

(2012) L. Mulrane et al.   CLINICAL CANCER RESEARCH

Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

(2012) J. S. Jang et al.   CLINICAL CANCER RESEARCH

Smoking at diagnosis and survival in cancer patients

(2012) Graham W. Warren et al.   INTERNATIONAL JOURNAL OF CANCER

Phospho-ΔNp63α is a key regulator of the cisplatin-induced microRNAome in cancer cells

(2011) Y Huang et al.   CELL DEATH AND DIFFERENTIATION

Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma

(2011) Ying-Fu Liu et al.   CLINICAL & EXPERIMENTAL METASTASIS

A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis

(2011) X. Tan et al.   CLINICAL CANCER RESEARCH

miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes

(2011) Harsh Dweep et al.   JOURNAL OF BIOMEDICAL INFORMATICS

MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2

(2011) Ji-guang Zhang et al.   Journal of Thoracic Oncology

MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

(2011) Liang Luo et al.   MEDICAL ONCOLOGY

Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

(2011) Akihiko Yoshizawa et al.   MODERN PATHOLOGY

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

(2011) Mattia Boeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer

(2010) Xiaobo Guo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments

(2010) James H Bullard et al.   BMC BIOINFORMATICS

MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer

(2010) M. T. Landi et al.   CLINICAL CANCER RESEARCH

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors

(2010) Xi Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

A scaling normalization method for differential expression analysis of RNA-seq data

(2010) Mark D Robinson et al.   GENOME BIOLOGY

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

(2009) M. D. Robinson et al.   BIOINFORMATICS

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

Impact of Environmental Tobacco Smoke on the Incidence of Mutations in Epidermal Growth Factor Receptor Gene in Never-Smoker Patients With Non–Small-Cell Lung Cancer

(2009) Young Joo Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

(2009) Tetsuya Mitsudomi et al.   LANCET ONCOLOGY

MicroRNA Signature Predicts Survival and Relapse in Lung Cancer

(2008) Sung-Liang Yu et al.   CANCER CELL

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology